Samsung Biologics Webinars
-
Downstream Strategies To Accelerate Preclinical Development Timelines
4/3/2024
As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.
-
Continuous Manufacturing: Challenges, Advantages Of N-1 Perfusion
Discover key considerations and challenges in implementing N-1 perfusion technology, as well as the impact of continuous technology on tech transfer and process scale-up.
-
Key Considerations When Outsourcing An Aseptic Fill/Finish Project To A CMO Partner
This presentation addresses keys to outsourced drug production, including the importance of seeking the right partnerships to help overcome the challenges associated with secure commercial product supply.
-
How COVID-19 Is Redefining Drug Development And Manufacturing
Unprecedented times provide opportunities to advance innovative technology, establish a robust business contingency plan, and reduce lead time to drug delivery.
-
All Eyes On mRNA: Addressing Key Insights Into The Next Blockbuster
With ongoing development efforts seeing infinite possibilities for cancers, autoimmune diseases, and genetic diseases, how should the industry apply this early victory into successful mRNA-based therapeutics and vaccines?
-
Accelerated Tech Transfer For A COVID-19 Program
This webinar describes the acceleration of tech transfer to enable kickoff to vial thaw for antibody manufacture within three months for a clinical program and five months for process qualification.
-
Biopharmaceutical Process Characterization
Here we present process development and characterization strategies required to support commercial scale manufacture of antibody therapeutics.